A differentiated approach to the management of patients with hyperplastic diseases of the uterus complicated by abnormal uterine bleeding
DOI:
https://doi.org/10.12775/JEHS.2023.13.05.022Keywords
endometrial hyperplasia, uterine myoma, adenomyosis, menstrual dysfunction, abnormal uterine bleeding, diagnosis, treatmentAbstract
The purpose: to justify a differentiated approach to the management of patients with hyperplastic uterine diseases complicated by abnormal uterine bleeding (AUB) based on the study of the morpho-functional features of the endo- and myometrium. It has been shown that PgR expression is low in patients with combined lesions of the endometrium and myometrium complicated by AMC. The degree of PgR expression has a strong negative correlation with pathological changes of the endometrial-myometrial junction (r=-0.71), which made it possible to consider these criteria in the creation of a differentiated algorithm for the management of patients taking into account clinical and morphological pathogenetic variants of the disease. The use of differentiated approaches to the treatment of patients with combined hyperplastic processes of the uterus, taking into account the clinical and morphological features of the disease, made it possible to reduce the number of recurrences of AMC and achieve a long-term clinical effect in comparison with traditional treatment.
References
Gladchuk IZ, Rozhkovska NM, Marichereda VG, Lomakina IS, Shpak IV, Zhelezov DM. Archimetra: imaging aspects of combined pathology of the endometrium and myometrium. Reproductive endocrinology. 2023;1(67):74-78.
Kruty YuYa, Zemlyana NA. Clinical anamnestic and immunoenzymatic predictors of recurrence of endometrial hyperplastic processes in combination with uterine myoma. RZH [Internet]. 31, December 2020 [cit. for 28, September 2023];5(5):48-52. available at: https://repro-health.com.ua/article/view/225119.
Vannuccini S, Tosti C, Carmona F, Huang SJ, Chapron C, Guo SW, Petraglia F. Pathogenesis of adenomyosis: an update on molecular mechanisms. Reprod Biomed Online. 2017 Nov;35(5):592-601. doi: 10.1016/j.rbmo.2017.06.016.
Krentel H, De Wilde RL. Prevalence of adenomyosis in women undergoing hysterectomy for abnormal uterine bleeding, pelvic pain or uterine prolapse - A retrospective cohort study. Ann Med Surg (Lond). 2022 May 23;78:103809. doi: 10.1016/j.amsu.2022.103809.
Rozhkovska NM, Lomakina IS. Immunohistochemical features of benign endometrial hyperplasia in premenopausal women. Reproductive endocrinology. 2020; 4: 39-45.
Lebduska E, Beshear D, Spataro BM. Abnormal Uterine Bleeding. Med Clin North Am. 2023 Mar;107(2):235-246. doi: 10.1016/j.mcna.2022.10.014.
Wouk N, Helton M. Abnormal Uterine Bleeding in Premenopausal Women. Am Fam Physician. 2019 Apr 1;99(7):435-443.
Walvir NM, Rana S, Jairajpuri ZS, Jetley S, Nigam A. A histopathological and immunohistochemistry analysis of endometrial lesions among women presenting with abnormal uterine bleeding. J Cancer Res Ther. 2022 Oct-Dec;18(6):1474-1484. doi: 10.4103/jcrt.JCRT_915_20.
Chodankar R, Critchley HOD. Biomarkers in abnormal uterine bleeding†. Biol Reprod. 2019 Dec 24;101(6):1155-1166. doi: 10.1093/biolre/ioy231.
Order of the Ministry of Health of Ukraine No. 676 dated December 31, 2004 "On approval of clinical protocols for obstetric and gynecological care."https://zakon.rada.gov.ua/rada/show/v0676282-04#Text
Order of the Ministry of Health of Ukraine No. 353 dated 04/13/2016 On the approval and implementation of medical and technological documents on the standardization of medical care for abnormal uterine bleeding. https://zakon.rada.gov.ua/rada/show/v0353282-16#Text
Order of the Ministry of Health of Ukraine No. 869 dated 05.05.2021 On approval of the Unified clinical protocol of primary, secondary (specialized), tertiary (highly specialized) medical care "Endometrial hyperplasia" https://zakon.rada.gov.ua/rada/show/v0869282-21#Text
Magnay JL, O'Brien S, Gerlinger C, Seitz C. A systematic review of methods to measure menstrual blood loss. BMC Womens Health. 2018 Aug 22;18(1):142. doi: 10.1186/s12905-018-0627-8.
Mansfield PK, Voda A, Allison G. Validating a pencil-and-paper measure of perimenopausal menstrual blood loss. Womens Health Issues. 2004 Nov-Dec;14(6):242-7. doi: 10.1016/j.whi.2004.07.005.
Ring KL, Mills AM, Modesitt SC. Endometrial Hyperplasia. Obstet Gynecol. 2022 Dec 1;140(6):1061-1075. doi: 10.1097/AOG.0000000000004989.
Munro MG, Critchley HOD, Fraser IS; FIGO Menstrual Disorders Committee. The two FIGO systems for normal and abnormal uterine bleeding symptoms and classification of causes of abnormal uterine bleeding in the reproductive years: 2018 revisions. Int J Gynaecol Obstet. 2018 Dec;143(3):393-408. doi: 10.1002/ijgo.12666.
Management of Endometrial Hyperplasia (Green-top Guideline No. 67). https://www.rcog.org.uk/media/knmjbj5c/gtg_67_endometrial_ hyperplasia.pdf
Modern aspects of ultrasound diagnostics in obstetrics and gynecology. LB Markin [and others]. Lviv: ZUKTS, 2018. 112 p.
Vareniuk IM, Dzerzhynskyi ME. Methods of cyto-histological diagnosis. Kyiv: Interservice, 2019. 256 p.
Zaporozhan VM, Aryaev ML. Bioethics and biosafety: Textbook Kyiv: Zdorovya, 2013. 456 p.
Babienko VV, Mokienko AV, Levkovska VYU. Biostatistics. Odesa: Press-courier, 2022. 180 p.
Fetisov VS. Package of statistical data analysis STATISTICA. Nizhin: NSU named after M. Gogol, 2018. 114 p.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 I. Lomakina, N. Rozhkovska, V. Sytnikova, S. Syviy
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
The periodical offers access to content in the Open Access system under the Creative Commons Attribution-NonCommercial-ShareAlike 4.0
Stats
Number of views and downloads: 156
Number of citations: 0
